
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| MB_CA_L | 72 | 9.8% | 5.46 | 3,159 | 98.4% |
| AL_L | 659 | 89.5% | -4.04 | 40 | 1.2% |
| PLP_L | 3 | 0.4% | 0.00 | 3 | 0.1% |
| LAL_L | 0 | 0.0% | inf | 3 | 0.1% |
| FB | 2 | 0.3% | -1.00 | 1 | 0.0% |
| MB_PED_L | 0 | 0.0% | inf | 3 | 0.1% |
| ICL_L | 0 | 0.0% | inf | 2 | 0.1% |
| upstream partner | # | NT | conns VP3+_vPN | % In | CV |
|---|---|---|---|---|---|
| TRN_VP3b (L) | 1 | ACh | 199 | 28.1% | 0.0 |
| VP3+VP1l_ivPN (R) | 1 | ACh | 87 | 12.3% | 0.0 |
| VP3+VP1l_ivPN (L) | 1 | ACh | 68 | 9.6% | 0.0 |
| VP3+_vPN (L) | 1 | GABA | 49 | 6.9% | 0.0 |
| VP3+_l2PN (L) | 3 | ACh | 46 | 6.5% | 0.5 |
| v2LN4 (R) | 3 | ACh | 42 | 5.9% | 0.4 |
| l2LN20 (L) | 2 | GABA | 32 | 4.5% | 0.3 |
| HRN_VP1l (L) | 6 | ACh | 32 | 4.5% | 0.7 |
| v2LN49 (L) | 2 | Glu | 22 | 3.1% | 0.2 |
| TRN_VP3a (L) | 3 | ACh | 18 | 2.5% | 0.1 |
| lLN2X12 (L) | 4 | ACh | 10 | 1.4% | 0.4 |
| lLN2X05 (L) | 2 | Unk | 9 | 1.3% | 0.1 |
| lLN2X06 (L) | 1 | Unk | 8 | 1.1% | 0.0 |
| lLN2X04 (L) | 2 | GABA | 8 | 1.1% | 0.2 |
| lLN2F_a (L) | 2 | GABA | 6 | 0.8% | 0.0 |
| SLP184 (L) | 1 | ACh | 5 | 0.7% | 0.0 |
| M_l2PNm16 (L) | 2 | ACh | 5 | 0.7% | 0.6 |
| VM6_adPN (L) | 1 | ACh | 4 | 0.6% | 0.0 |
| lLN1_bc (L) | 4 | Unk | 4 | 0.6% | 0.0 |
| v2LN41a (R) | 1 | Unk | 3 | 0.4% | 0.0 |
| lLN2X11 (L) | 2 | 5-HT | 3 | 0.4% | 0.3 |
| lLN2X03 (L) | 2 | 5-HT | 3 | 0.4% | 0.3 |
| KCg-m (L) | 3 | ACh | 3 | 0.4% | 0.0 |
| VP1m+_lvPN (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| OA-VUMa2 (M) | 1 | OA | 2 | 0.3% | 0.0 |
| lLN2T_e (L) | 1 | Unk | 2 | 0.3% | 0.0 |
| lLN2X07 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| LHAD4a1 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| VP3+_l2PN (R) | 1 | ACh | 2 | 0.3% | 0.0 |
| v2LN38 (L) | 1 | Unk | 2 | 0.3% | 0.0 |
| VP2_adPN (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| v2LN41b (L) | 1 | Unk | 2 | 0.3% | 0.0 |
| CB3709 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| lLN2F_b (L) | 2 | GABA | 2 | 0.3% | 0.0 |
| l2LN22 (L) | 2 | GABA | 2 | 0.3% | 0.0 |
| v2LN39a (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| PS291 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| v2LN4 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| v2LN41b (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| OA-VUMa5 (M) | 1 | OA | 1 | 0.1% | 0.0 |
| SMP163 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| VP4_vPN (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| CB1266 (L) | 1 | Unk | 1 | 0.1% | 0.0 |
| v2LN41a (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| DN1-l (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| KCg-s2 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| ALIN5 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| v2LNX01 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| SAD034 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| DN1a (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| VP1l+VP3_ilPN (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| M_vPNml60 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| lLN2P_b (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| VC5_lvPN (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| downstream partner | # | NT | conns VP3+_vPN | % Out | CV |
|---|---|---|---|---|---|
| LHAV3q1 (L) | 1 | ACh | 173 | 15.2% | 0.0 |
| KCapbp-ap1 (L) | 13 | ACh | 160 | 14.1% | 0.6 |
| SLP184 (L) | 1 | ACh | 151 | 13.3% | 0.0 |
| DN1a (L) | 2 | Glu | 127 | 11.2% | 0.2 |
| VP2_adPN (L) | 1 | ACh | 70 | 6.2% | 0.0 |
| DN1-l (L) | 1 | Glu | 67 | 5.9% | 0.0 |
| LHPD5a1 (L) | 1 | Glu | 53 | 4.7% | 0.0 |
| VP3+_vPN (L) | 1 | GABA | 49 | 4.3% | 0.0 |
| KCg-s2 (L) | 1 | ACh | 44 | 3.9% | 0.0 |
| VP2+_adPN (L) | 1 | ACh | 37 | 3.3% | 0.0 |
| SMP421 (L) | 1 | ACh | 33 | 2.9% | 0.0 |
| LHPV6r1 (L) | 2 | ACh | 28 | 2.5% | 0.4 |
| SLP210 (L) | 1 | ACh | 20 | 1.8% | 0.0 |
| CB1218 (L) | 1 | Glu | 18 | 1.6% | 0.0 |
| VM6_adPN (L) | 1 | ACh | 16 | 1.4% | 0.0 |
| LHPV4c3, LHPV4c4 (L) | 2 | Glu | 15 | 1.3% | 0.1 |
| CB1511 (L) | 2 | Glu | 12 | 1.1% | 0.3 |
| KCg-m (L) | 11 | ACh | 11 | 1.0% | 0.0 |
| LHAV4i1 (L) | 1 | GABA | 6 | 0.5% | 0.0 |
| KCg-s1 (L) | 1 | ACh | 5 | 0.4% | 0.0 |
| LHAV2d1 (L) | 1 | ACh | 4 | 0.4% | 0.0 |
| SMP345 (L) | 1 | Glu | 4 | 0.4% | 0.0 |
| LHPV6f1 (L) | 1 | ACh | 3 | 0.3% | 0.0 |
| MBON20 (L) | 1 | GABA | 2 | 0.2% | 0.0 |
| VP1m+_lvPN (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| M_ilPNm90,M_ilPN8t91 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| l2LN20 (L) | 1 | GABA | 2 | 0.2% | 0.0 |
| VP3+VP1l_ivPN (R) | 1 | ACh | 2 | 0.2% | 0.0 |
| SLP364 (L) | 2 | Glu | 2 | 0.2% | 0.0 |
| lLN2F_a (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| CB0130 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| lLN2T_e (L) | 1 | Unk | 1 | 0.1% | 0.0 |
| CB3206 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| DP1l_vPN (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| SMP112 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| KCab (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP457 (L) | 1 | DA | 1 | 0.1% | 0.0 |
| v2LN49 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| PPL202 (L) | 1 | DA | 1 | 0.1% | 0.0 |
| VP1l+_lvPN (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| APL (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| CB1545 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LHPV10c1 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| SLP066 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| VP3+_l2PN (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| v2LN38 (L) | 1 | Unk | 1 | 0.1% | 0.0 |
| VP3+VP1l_ivPN (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB3709 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| AVLP446 (L) | 1 | GABA | 1 | 0.1% | 0.0 |